Research Article
Off Time Independently Affects Quality of Life in Advanced Parkinson’s Disease (APD) Patients but Not in Non-APD Patients: Results from the Self-Reported Japanese Quality-of-Life Survey of Parkinson’s Disease (JAQPAD) Study
Table 1
Baseline demographics and clinical characteristics.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unknown/missing data are not listed. Continuous subcutaneous apomorphine infusion is not approved in Japan. APD: advanced Parkinson’s disease; DBS: deep brain stimulation; EQ-5D-5L-SI: European Quality-of-Life 5-Dimension, 5-Level Version Questionnaire Summary Index; EQ-VAS: European Quality-of-Life–Visual Analogue Scale; H&Y: Hoehn and Yahr; LCIG: levodopa-carbidopa intestinal gel; NMSQ-TS: Nonmotor Symptoms Questionnaire Total Score; PD: Parkinson’s disease; PDQ-8 SI: 8-item Parkinson’s Disease Questionnaire Summary Index; SD: standard deviation; SE-ADL: Schwab and England Activities of Daily Living; WO: wearing-off; WOQ-9: 9-item Wearing-Off Questionnaire. |